Cargando…
Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
Genomic sequencing has driven precision-based oncology therapy; however, genetic drivers remain unknown or non-targetable for many malignancies, demanding alternative approaches to identify therapeutic leads. Ependymomas are chemotherapy-resistant brain tumours, which, despite genomic sequencing, la...
Ejemplares similares
-
Integrative genomic analysis of human ribosomal DNA
por: Zentner, Gabriel E., et al.
Publicado: (2011) -
RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019) -
PRC2 Is Dispensable in Vivo for β-Catenin-Mediated Repression of Chondrogenesis in the Mouse Embryonic Cranial Mesenchyme
por: Ferguson, James, et al.
Publicado: (2017) -
A functional genomics approach to identify pathways of drug resistance in medulloblastoma
por: Bertrand, Kelsey C., et al.
Publicado: (2018) -
Colon Cancer-Upregulated Long Non-Coding RNA lincDUSP Regulates Cell Cycle Genes and Potentiates Resistance to Apoptosis
por: Forrest, Megan E., et al.
Publicado: (2018)